The IARC TP53 database shows that TP53 mutations are not as common in hematological malignancies as in other types of cancer (approximately 5.89%, compared with 12.77% in colorectal cancer and 10.2% in breast cancer). The gene discussed is TP53; the disease is colorectal cancer.